We are live on ! Find out more
FMWA

Forvis Mazars Wealth Advisors Portfolio holdings

AUM $5.27B
1-Year Est. Return 18.06%
This Fund
S&P 500
This Quarter Est. Return
-0.62%
1 Year Est. Return
+18.06%
3 Year Est. Return
+51.15%
5 Year Est. Return
+52.01%
10 Year Est. Return
+190.2%
AUM
$2.18B
AUM Growth
+$27.3M
Cap. Flow
+$44M
Cap. Flow %
2.02%
Top 10 Hldgs %
66.55%
Holding
282
New
21
Increased
122
Reduced
94
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 4.85%
2 Healthcare 2.55%
3 Financials 2.35%
4 Consumer Discretionary 1.7%
5 Consumer Staples 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CF icon
101
CF Industries
CF
$19.3B
$1.82M 0.08%
32,561
+992
+3% +$47.6K
IBDP
102
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
0
TRV icon
103
Travelers Companies
TRV
$78.4B
$1.79M 0.08%
11,783
+508
+5% +$78.6K
XLC icon
104
State Street Communication Services Select Sector SPDR ETF
XLC
$21.9B
$1.77M 0.08%
22,062
-40
-0.2% -$3.31K
DRI icon
105
Darden Restaurants
DRI
$23.7B
$1.74M 0.08%
11,511
+759
+7% +$112K
VLO icon
106
Valero Energy
VLO
$92.6B
$1.72M 0.08%
24,313
+1,018
+4% +$67.8K
MCD icon
107
McDonald's
MCD
$191B
$1.64M 0.08%
6,820
+439
+7% +$105K
PRFZ icon
108
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.77B
$1.64M 0.08%
44,960
-45
-0.1% -$1.65K
CL icon
109
Colgate-Palmolive
CL
$73.3B
$1.64M 0.08%
21,659
-466
-2% -$37K
ROP icon
110
Roper Technologies
ROP
$38.5B
$1.61M 0.07%
3,611
+117
+3% +$56.1K
F icon
111
Ford
F
$59.3B
$1.6M 0.07%
112,807
-120
-0.1% -$1.63K
XLB icon
112
State Street Materials Select Sector SPDR ETF
XLB
$8.71B
$1.58M 0.07%
40,062
+298
+0.7% +$12.4K
CVS icon
113
CVS Health
CVS
$134B
$1.58M 0.07%
18,622
+26
+0.1% +$2.18K
DHR icon
114
Danaher
DHR
$138B
$1.56M 0.07%
5,770
-67
-1% -$18.2K
UNM icon
115
Unum
UNM
$13.7B
$1.53M 0.07%
60,965
+3,814
+7% +$101K
OEF icon
116
iShares S&P 100 ETF
OEF
$19.9B
$1.51M 0.07%
7,661
-53
-0.7% -$10.8K
UNP icon
117
Union Pacific
UNP
$172B
$1.49M 0.07%
7,601
+583
+8% +$126K
SPYG icon
118
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51B
$1.43M 0.07%
22,323
+4,011
+22% +$265K
KO icon
119
Coca-Cola
KO
$381B
$1.41M 0.07%
26,951
-366
-1% -$20.4K
PEG icon
120
Public Service Enterprise Group
PEG
$38.6B
$1.41M 0.06%
23,197
+1,131
+5% +$70.6K
REGN icon
121
Regeneron Pharmaceuticals
REGN
$77.4B
$1.41M 0.06%
2,322
+1,738
+298% +$1.08M
TIP icon
122
iShares TIPS Bond ETF
TIP
$14.5B
$1.29M 0.06%
10,137
+97
+1% +$12.5K
GOVT icon
123
iShares US Treasury Bond ETF
GOVT
$43.7B
$1.27M 0.06%
47,986
-18,222
-28% -$488K
AMP icon
124
Ameriprise Financial
AMP
$48.1B
$1.26M 0.06%
4,784
+146
+3% +$38.2K
VIGI icon
125
Vanguard International Dividend Appreciation ETF
VIGI
$9.15B
$1.23M 0.06%
14,118
+38
+0.3% +$3.4K

Similar funds

Forvis Mazars Wealth Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Forvis Mazars Wealth Advisors held 282 positions worth $2.18B, up 1.3% from $2.15B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Forvis Mazars Wealth Advisors's Q3 2021 filing shows 21 new, 122 increased, 94 reduced and 10 closed positions. Its largest new stake was Cerner Corp: 12,123 shares worth $855K. The largest sale was Alexion Pharmaceuticals, an estimated $2.27M.

By sector, the portfolio is most concentrated in Technology at 4.8% of assets, up from 4.8% a quarter earlier, followed by Healthcare and Financials.

  • Forvis Mazars Wealth Advisors's largest Q3 2021 buy was Cerner Corp: 12,123 shares worth $855K.
  • Forvis Mazars Wealth Advisors added most to Vanguard FTSE All-World ex-US ETF in Q3 2021, an estimated $9.71M increase.
  • Forvis Mazars Wealth Advisors's biggest Q3 2021 reduction was iShares S&P 500 Growth ETF, cutting an estimated $972K.
  • Forvis Mazars Wealth Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $2.27M.
  • Forvis Mazars Wealth Advisors's ten largest holdings make up 67% of its $2.18B portfolio in Q3 2021.
  • Forvis Mazars Wealth Advisors opened 21 new positions and closed 10 in Q3 2021.
  • Forvis Mazars Wealth Advisors's portfolio value rose 1.3% quarter-over-quarter to $2.18B.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q3 2021, filed 14 Oct 2021.